Millennium: The Takeda Oncology Company
Deborah Dunsire, MD
President and Chief Executive Officer
CancerCare is grateful to Millennium: The Takeda Oncology Company and its President and Chief Executive Officer, Deborah Dunsire, MD, for their commitment to providing the latest information to people affected by cancer through their support of our free educational programs. Dr. Dunsire joined Millennium in July 2005 with nearly 20 years of experience in commercial, operational, clinical and scientific aspects of a world-leading pharmaceutical business. Her vision for Millennium is to establish a vibrant, growing biotechnology company, which discovers and develops new medicines that change the standards of care in cancer. Dr. Dunsire previously led the Novartis U.S. Oncology business, and played a critical role in the development and launch of many successful products. She is a longtime member of CancerCare’s Board of Trustees, and also serves on the boards of Biotechnology Industry Organization, Allergan, Inc., the Museum of Science, and the G&P Foundation for Cancer Research. Dr. Dunsire’s recent honors and awards include the Healthcare Businesswomen’s Association’s “Woman of the Year Award” in 2009 and the 2011 MassBio Innovative Leadership award.